Overview

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
A placebo controlled, double-blind and randomized study to assess different doses of a new drug (BAY58-2667) given intravenously, to evaluate if it is safe and can help to improve the well-being of patients with acute decompensated heart failure.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer